Event Listing

Camille is a UK and European Patent Attorney specialising in computational modelling and data driven approaches to life sciences including bioinformatics, digital health, AI in therapeutics, health and biology, and advanced bioprocessing.

She has a PhD in Bioinformatics (Cambridge University), and Master’s in Computational Biology (Cambridge University) and Bioengineering (Brussels University). She is a partner in Mewburn Ellis’s Cambridge office. She advises clients from biotech start ups and TTOs to large pharma in how best to protect, defend and deal with IP related to data driven and in silico technologies.

Matthew is a UPC Representative and Chartered and European Patent Attorney. He is a Partner and Litigator at Mewburn Ellis. He handles patent and design work in the fields of materials and engineering. His work encompasses drafting, prosecution, opposition, dispute resolution and litigation – all stages of the patent life cycle. Matthew has a degree and PhD in materials science from the University of Oxford. His focus is on helping clients to navigate the opportunities and challenges of the Unified Patent Court.

Matthew is handling several substantive UPC actions along with technical specialists at Mewburn Ellis, in addition to advising on ongoing UPC actions represented by other European firms.

As the founder and lead author of UPC Weekly, Matthew devotes a significant part of each week to reviewing and commenting on UPC case law and educating fellow attorneys and lawyers.

Alex Wilson is a founding partner of Powell Gilbert www.powellgilbert.com, a specialist European IP law firm with offices in London, Dusseldorf, and Dublin.

He is a UK Solicitor Advocate, Irish Solicitor and UPC Representative. He guides clients from a wide range of industries on strategies for exploiting and enforcing of patents in national and UPC courts across Europe as well other major markets. He has handled a number of the leading SEP cases in the UPC and is on the PMAC FRAND Guidelines Working Group.

He is joint editor of an international commentary: Unified Patent Court Procedure, Beck 2025 and was actively involved in teaching legal and technical Judges for the Court. Alex is a Vice President of the European Patent Lawyers’ Association (EPLAW) and chairs its Japan and Korea Outreach and ADR committees.

Amy is a UK solicitor and patent litigation partner at Mewburn Ellis, with over 15 years’ experience of acting for clients in the pharmaceutical and biotech industries. Her experience spans the full spectrum of life sciences patent disputes before the UK courts, ranging from small molecule and antibody disputes to the UK’s first gene therapy patent case to go to trial. She also has extensive experience of coordinating multi-jurisdictional litigation across Europe and with the US, as well as aligning litigation strategy with opposition proceedings before the EPO.

Amy also has experience of acting for clients on UPC litigation and of advising clients on the ever-increasing importance of UPC litigation strategy and its integration with UK and European national litigation strategy. She is currently acting for a global pharmaceutical company in a UPC infringement suit for a CAR-T cell therapy.

Amy is also the co-chair of the London chapter of ChIPs, a high-profile IP organisation that acts to promote women in tech, law and policy.

Camille is a UK and European Patent Attorney specialising in computational modelling and data driven approaches to life sciences including bioinformatics, digital health, AI in therapeutics, health and biology, and advanced bioprocessing.

She has a PhD in Bioinformatics (Cambridge University), and Master’s in Computational Biology (Cambridge University) and Bioengineering (Brussels University). She is a partner in Mewburn Ellis’s Cambridge office. She advises clients from biotech start ups and TTOs to large pharma in how best to protect, defend and deal with IP related to data driven and in silico technologies.